SG10201509679XA - Methods for production and uses of multipotent cell populations - Google Patents
Methods for production and uses of multipotent cell populationsInfo
- Publication number
- SG10201509679XA SG10201509679XA SG10201509679XA SG10201509679XA SG10201509679XA SG 10201509679X A SG10201509679X A SG 10201509679XA SG 10201509679X A SG10201509679X A SG 10201509679XA SG 10201509679X A SG10201509679X A SG 10201509679XA SG 10201509679X A SG10201509679X A SG 10201509679XA
- Authority
- SG
- Singapore
- Prior art keywords
- production
- methods
- cell populations
- multipotent cell
- multipotent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/31—Combination therapy
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93202007P | 2007-05-29 | 2007-05-29 | |
US93313307P | 2007-06-05 | 2007-06-05 | |
US93367007P | 2007-06-08 | 2007-06-08 | |
US644908P | 2008-01-14 | 2008-01-14 | |
US6476108P | 2008-03-25 | 2008-03-25 | |
PCT/US2008/065007 WO2008150814A2 (en) | 2007-05-29 | 2008-05-28 | Methods for production and uses of multipotent cell populations |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201509679XA true SG10201509679XA (en) | 2015-12-30 |
Family
ID=40094346
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201903161XA SG10201903161XA (en) | 2007-05-29 | 2008-05-28 | Methods for production and uses of multipotent cell populations |
SG10201509679XA SG10201509679XA (en) | 2007-05-29 | 2008-05-28 | Methods for production and uses of multipotent cell populations |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201903161XA SG10201903161XA (en) | 2007-05-29 | 2008-05-28 | Methods for production and uses of multipotent cell populations |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110217274A1 (en) |
EP (2) | EP2164993B1 (en) |
JP (2) | JP2010528613A (en) |
CN (2) | CN105586358B (en) |
AU (1) | AU2008260187A1 (en) |
BR (1) | BRPI0810949A2 (en) |
CA (1) | CA2725953A1 (en) |
ES (1) | ES2612538T3 (en) |
HU (1) | HUE030872T2 (en) |
IL (2) | IL202401A (en) |
PL (1) | PL2164993T3 (en) |
PT (1) | PT2164993T (en) |
RU (2) | RU2535365C2 (en) |
SG (2) | SG10201903161XA (en) |
WO (1) | WO2008150814A2 (en) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8129187B2 (en) | 2005-12-13 | 2012-03-06 | Kyoto University | Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2 |
EP2206724A1 (en) | 2005-12-13 | 2010-07-14 | Kyoto University | Nuclear reprogramming factor |
US8278104B2 (en) | 2005-12-13 | 2012-10-02 | Kyoto University | Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2 |
SG193652A1 (en) | 2007-03-23 | 2013-10-30 | Wisconsin Alumni Res Found | Somatic cell reprogramming |
US11859168B2 (en) * | 2007-05-29 | 2024-01-02 | Christopher B. REID | Electroporation, developmentally-activated cells, pluripotent-like cells, cell reprogramming and regenerative medicine |
US9213999B2 (en) | 2007-06-15 | 2015-12-15 | Kyoto University | Providing iPSCs to a customer |
JP2008307007A (en) | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth |
US20100279404A1 (en) | 2008-05-02 | 2010-11-04 | Shinya Yamanaka | Method of nuclear reprogramming |
DK2297307T3 (en) | 2008-06-04 | 2016-07-25 | Cellular Dynamics Int Inc | PROCEDURES FOR THE MANUFACTURE OF IPS CELLS USING NON-VIRAL METHODS |
WO2010019569A1 (en) * | 2008-08-12 | 2010-02-18 | Cellular Dynamics International. Inc. | Methods for the production of ips cells |
JP2010148440A (en) * | 2008-12-25 | 2010-07-08 | Japan Health Science Foundation | System for quickly constructing recombinant adenovirus |
EP2425001A4 (en) * | 2009-04-30 | 2012-11-14 | Univ California | Combination anti-hiv vectors, targeting vectors, and methods of use |
US9365866B2 (en) * | 2009-06-03 | 2016-06-14 | National Institute Of Advanced Industrial Science And Technology | Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same |
US9453205B2 (en) * | 2009-10-31 | 2016-09-27 | Genesis Technologies Limited | Methods for reprogramming cells and uses thereof |
CN102947444A (en) * | 2010-06-23 | 2013-02-27 | 帷幄生物技术公司 | Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
US8835400B2 (en) | 2010-10-08 | 2014-09-16 | Mina Therapeutics Limited | RNA molecules that upregulate insulin production |
WO2012061075A2 (en) * | 2010-10-25 | 2012-05-10 | The Regents Of The University Of California | Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells |
DK2633052T3 (en) * | 2010-10-27 | 2018-07-16 | Curna Inc | TREATMENT OF INTERFERON-RELATED DEVELOPMENT REGULATOR 1 (IFRD1) -RELATED DISEASES BY INHIBITION OF NATURAL ANTISENCE TRANSCRIPT TO IFRD1 |
KR20210134808A (en) * | 2011-12-05 | 2021-11-10 | 팩터 바이오사이언스 인크. | Methods and products for transfecting cells |
CN102659951A (en) * | 2012-05-29 | 2012-09-12 | 西安医学院 | TAT (Trans-activating factor) kringle domain-modified nenurogenin2 fusion protein, as well as preparation method thereof and application thereof |
WO2014035433A1 (en) * | 2012-08-31 | 2014-03-06 | Jan Nolta | Genetically modified msc and therapeutic methods |
US20140065110A1 (en) | 2012-08-31 | 2014-03-06 | The Regents Of The University Of California | Genetically modified msc and therapeutic methods |
US9663564B2 (en) | 2013-03-15 | 2017-05-30 | The Regents Of The University Of California | Vectors and methods to treat ischemia |
US20140271923A1 (en) | 2013-03-14 | 2014-09-18 | Christopher Brian Reid | Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions |
CA2930973A1 (en) | 2013-11-22 | 2015-05-28 | Pal SAERTROM | C/ebp alpha short activating rna compositions and methods of use |
EP3929298A1 (en) * | 2015-03-09 | 2021-12-29 | Sinai Health System | Tools and methods for using cell division loci to control proliferation of cells |
CA2991213A1 (en) * | 2015-07-02 | 2017-01-05 | Medigen, Inc. | Recombinant virus like particles using bovine immunodeficiency virus gag protein |
EP3319631A4 (en) * | 2015-07-08 | 2019-01-09 | American Gene Technologies International Inc. | Hiv pre-immunization and immunotherapy |
KR20170007181A (en) | 2015-07-10 | 2017-01-18 | 3스캔 인크. | Spatial multiplexing of histological stains |
WO2017117521A1 (en) | 2015-12-31 | 2017-07-06 | Berkeley Lights, Inc. | Tumor infilitrating cells engineered to express a pro-inflammatory polypeptide |
EP3429753A4 (en) | 2016-03-16 | 2019-11-06 | Berkeley Lights, Inc. | Methods, systems and devices for selection and generation of genome edited clones |
CA3066107A1 (en) | 2016-06-03 | 2017-12-07 | Hough Ear Institute | Combination therapies for inner ear sensory hair cell regeneration/replacement |
CN106086075B (en) * | 2016-06-23 | 2019-08-06 | 福建医科大学 | The construction method of CXCR4RNAi slow virus carrier |
AU2017298385A1 (en) * | 2016-07-19 | 2019-03-07 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Oncolytic viruses targeting STAT3 |
CN106497882A (en) * | 2016-10-29 | 2017-03-15 | 复旦大学 | The cell strain of overexpression R spondin1 and Noggin and its construction method and application simultaneously |
WO2018126205A1 (en) | 2016-12-30 | 2018-07-05 | The Regents Of The University Of California | Methods for selection and generation of genome edited t cells |
CN108977463A (en) * | 2017-05-31 | 2018-12-11 | 伯仕利生物科技发展(盐城)有限公司 | A kind of technical method for inhibiting production to be broken up with stem cell |
US20210363486A1 (en) | 2018-02-09 | 2021-11-25 | Kyoto University | Cardiomyocyte proliferation promoting agent and use thereof |
WO2019165320A1 (en) * | 2018-02-22 | 2019-08-29 | Celularity, Inc. | Post partum tissue-derived induced pluripotent stem cells and uses thereof |
CN108715868A (en) * | 2018-05-31 | 2018-10-30 | 深圳市免疫基因治疗研究院 | A kind of Gaucher slow virus carriers, slow virus and its preparation method and application |
CN111484977B (en) * | 2019-01-25 | 2023-05-16 | 中国科学院脑科学与智能技术卓越创新中心 | Method of reprogramming to produce functional noradrenergic neurons |
CN110283779A (en) * | 2019-07-17 | 2019-09-27 | 吉林省农业科学院 | A kind of isolated culture method and culture medium of chicken embryonic stem cells |
WO2022072310A1 (en) * | 2020-09-29 | 2022-04-07 | NeuExcell Therapeutics Inc. | Dlx2 vector |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2395698A (en) | 1943-12-18 | 1946-02-26 | Walter J Mathieu | Electric switch |
US4361552A (en) | 1980-09-26 | 1982-11-30 | Board Of Regents, The University Of Texas System | Wound dressing |
US5032508A (en) | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US4956178A (en) | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
US4902508A (en) | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
JP2710967B2 (en) * | 1988-11-22 | 1998-02-10 | 株式会社日立製作所 | Manufacturing method of integrated circuit device |
US7479269B2 (en) | 1988-11-23 | 2009-01-20 | Genetics Institute, Llc | Methods for selectively enriching TH1 and TH2 cells |
US5281422A (en) | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
US5453357A (en) | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
DE69434447T2 (en) | 1993-06-07 | 2006-05-18 | Vical, Inc., San Diego | PLASMIDE FOR GENE THERAPY |
US6217867B1 (en) | 1993-09-13 | 2001-04-17 | University Of Pittsburgh | Non-lethal methods for conditioning a recipient for bone marrow transplantation |
US6432711B1 (en) | 1993-11-03 | 2002-08-13 | Diacrin, Inc. | Embryonic stem cells capable of differentiating into desired cell lines |
US5928944A (en) | 1994-02-04 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method of adenoviral-medicated cell transfection |
US5484720A (en) | 1994-09-08 | 1996-01-16 | Genentech, Inc. | Methods for calcium phosphate transfection |
US5824547A (en) | 1994-11-29 | 1998-10-20 | Takara Shuzo Co., Ltd. | Method for production of transfected cells |
US5554389A (en) | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
US5677139A (en) | 1995-04-21 | 1997-10-14 | President And Fellows Of Harvard College | In vitro differentiation of CD34+ progenitor cells into T lymphocytes |
GB9518606D0 (en) * | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
US5783566A (en) | 1996-05-10 | 1998-07-21 | California Institute Of Technology | Method for increasing or decreasing transfection efficiency |
WO1998022158A2 (en) | 1996-08-23 | 1998-05-28 | Cook Biotech, Incorporated | Graft prosthesis, materials and methods |
EP0946186B1 (en) | 1996-12-10 | 2003-03-26 | Purdue Research Foundation | Stomach submucosa derived tissue graft |
AU746318B2 (en) | 1997-04-11 | 2002-04-18 | Cryolife, Inc. | Tissue decellularization |
DE69830663T2 (en) * | 1997-09-24 | 2006-05-11 | The Regents Of The University Of California, Oakland | Non-primate lentivirus vectors and packaging systems |
US6734018B2 (en) | 1999-06-07 | 2004-05-11 | Lifenet | Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced |
CN1137723C (en) | 1999-06-22 | 2004-02-11 | 研究发展基金会 | Enhanced wound converage to enhance wound healing |
US6479064B1 (en) | 1999-12-29 | 2002-11-12 | Children's Medical Center Corporation | Culturing different cell populations on a decellularized natural biostructure for organ reconstruction |
US6376244B1 (en) | 1999-12-29 | 2002-04-23 | Children's Medical Center Corporation | Methods and compositions for organ decellularization |
AU2001284968B2 (en) | 2000-08-16 | 2006-12-21 | Duke University | Decellularized tissue engineered constructs and tissues |
US6733993B2 (en) * | 2000-09-15 | 2004-05-11 | Merck & Co., Inc. | Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications |
AU2001292917A1 (en) | 2000-09-20 | 2002-04-02 | Regeneration Technologies, Inc. | Method of preparing and processing transplant tissue |
US6995013B2 (en) | 2002-07-08 | 2006-02-07 | Biomed Solutions, Llc | Cell-scaffold composition containing five layers |
US7211247B2 (en) | 2001-04-09 | 2007-05-01 | University Of Southern California | Lentivirus vectors for gene transfer to alveolar epithelial cells |
US7087089B2 (en) | 2001-06-28 | 2006-08-08 | Cook Biotech Incorporated | Graft prosthesis devices containing renal capsule collagen |
WO2003020191A1 (en) | 2001-09-04 | 2003-03-13 | University Of Iowa Research Foundation | Cellulose membranes for biodegradable scaffolds |
US20030109037A1 (en) * | 2001-09-24 | 2003-06-12 | Reid Christopher Brian | Methods for application of genetically-modified endogenous or exogenous stem/progenitor or their progeny for treatment of disease |
US20030099621A1 (en) | 2001-11-29 | 2003-05-29 | Robert Chow | Stem cell screening and transplantation therapy for HIV infection |
US7297540B2 (en) | 2002-01-15 | 2007-11-20 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs |
CA2476917A1 (en) | 2002-02-19 | 2003-08-28 | Bioarttis, Inc. | Artificial vessel scaffold and artificial organs therefrom |
AU2004206232A1 (en) * | 2003-01-17 | 2004-08-05 | University Of Florida Research Foundation Inc. | Small interference RNA gene therapy |
ES2547139T3 (en) | 2005-08-26 | 2015-10-02 | Regents Of The University Of Minnesota | Decellularization and recelularization of organs and tissues |
EP2206724A1 (en) * | 2005-12-13 | 2010-07-14 | Kyoto University | Nuclear reprogramming factor |
-
2008
- 2008-05-28 ES ES08769761.1T patent/ES2612538T3/en active Active
- 2008-05-28 EP EP08769761.1A patent/EP2164993B1/en active Active
- 2008-05-28 WO PCT/US2008/065007 patent/WO2008150814A2/en active Application Filing
- 2008-05-28 JP JP2010510472A patent/JP2010528613A/en active Pending
- 2008-05-28 US US12/601,819 patent/US20110217274A1/en not_active Abandoned
- 2008-05-28 PL PL08769761T patent/PL2164993T3/en unknown
- 2008-05-28 CN CN201510680523.XA patent/CN105586358B/en active Active
- 2008-05-28 BR BRPI0810949A patent/BRPI0810949A2/en not_active Application Discontinuation
- 2008-05-28 HU HUE08769761A patent/HUE030872T2/en unknown
- 2008-05-28 RU RU2009148666/10A patent/RU2535365C2/en active
- 2008-05-28 SG SG10201903161XA patent/SG10201903161XA/en unknown
- 2008-05-28 CN CN200880101094.4A patent/CN101772580B/en active Active
- 2008-05-28 CA CA2725953A patent/CA2725953A1/en not_active Abandoned
- 2008-05-28 EP EP16189709.5A patent/EP3128015A3/en not_active Withdrawn
- 2008-05-28 AU AU2008260187A patent/AU2008260187A1/en not_active Abandoned
- 2008-05-28 PT PT87697611T patent/PT2164993T/en unknown
- 2008-05-28 SG SG10201509679XA patent/SG10201509679XA/en unknown
-
2009
- 2009-11-29 IL IL202401A patent/IL202401A/en active IP Right Grant
-
2014
- 2014-10-02 RU RU2014139904A patent/RU2718536C2/en active
- 2014-11-10 JP JP2014227688A patent/JP2015077132A/en active Pending
-
2015
- 2015-10-06 IL IL241906A patent/IL241906B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL241906A0 (en) | 2015-11-30 |
RU2009148666A (en) | 2011-07-10 |
EP2164993A4 (en) | 2011-04-13 |
CN105586358B (en) | 2020-08-25 |
HUE030872T2 (en) | 2017-06-28 |
AU2008260187A1 (en) | 2008-12-11 |
US20110217274A1 (en) | 2011-09-08 |
RU2014139904A (en) | 2016-04-20 |
EP2164993A2 (en) | 2010-03-24 |
EP2164993B1 (en) | 2016-09-21 |
JP2015077132A (en) | 2015-04-23 |
IL241906B (en) | 2021-07-29 |
RU2014139904A3 (en) | 2018-06-28 |
RU2718536C2 (en) | 2020-04-08 |
IL202401A (en) | 2015-10-29 |
ES2612538T3 (en) | 2017-05-17 |
EP3128015A2 (en) | 2017-02-08 |
JP2010528613A (en) | 2010-08-26 |
CN105586358A (en) | 2016-05-18 |
EP3128015A3 (en) | 2017-05-03 |
CN101772580A (en) | 2010-07-07 |
CN101772580B (en) | 2015-11-25 |
IL202401A0 (en) | 2011-08-01 |
RU2535365C2 (en) | 2014-12-10 |
PT2164993T (en) | 2017-01-12 |
SG10201903161XA (en) | 2019-05-30 |
WO2008150814A3 (en) | 2009-02-05 |
CA2725953A1 (en) | 2008-12-11 |
PL2164993T4 (en) | 2017-08-31 |
BRPI0810949A2 (en) | 2015-10-27 |
WO2008150814A8 (en) | 2009-07-30 |
WO2008150814A2 (en) | 2008-12-11 |
PL2164993T3 (en) | 2017-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL241906B (en) | Methods for production and uses of multipotent cell populations | |
IL276146A (en) | In vitro methods for increasing viability of immune-cells | |
HK1216905A1 (en) | Differentiation of pluripotent stem cells | |
IL202678A0 (en) | Multipotent/pluripotent cells and methods | |
GB0622394D0 (en) | Differentiation of pluripotent cells | |
ZA201008391B (en) | Pluripotent cells | |
IL210638A0 (en) | Production of pluripotent cells through inhibition of bright/arid3a function | |
IL214818A0 (en) | Differentiation of pluripotent cells | |
EP2391711A4 (en) | Novel cell lines and methods | |
EP2108043A4 (en) | Novel methods and reagents directed to production of cells | |
ZA201008392B (en) | Treatment of pluripotent cells | |
EP2025689A4 (en) | Process for production of polyradical compound and battery cell | |
IL216871A0 (en) | Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells | |
EP2154243A4 (en) | Method for production of dendritic cell | |
EP2227540A4 (en) | De-differentiation of human cells | |
IL214783A (en) | Methods of reprogramming renal cells and renal cell populations obtained thereby | |
EP2294182A4 (en) | Multipotent stem cell cultures | |
EP2492341A4 (en) | Multipotent nestin-positive cells | |
ZA201000014B (en) | Methods for production and uses of multipotent cell populations | |
EP2202295A4 (en) | Method for efficient production of monocyte-derived multipotent cell (momc) | |
EP2351846A4 (en) | Use of cyclodextrins for the production and extraction of phytosterols in cell cultures | |
HK1157387A1 (en) | Use of hsa-producing cells | |
EP2185685A4 (en) | Novel methods and cell lines | |
GB0808280D0 (en) | Methods of preparing cell populations | |
AU2009901210A0 (en) | Epithelial progenitor cell and method of use |